MedTrace Logo

Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

NCT00705471 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2015-04-08

No results posted yet for this study

Summary

A multi-centre retrospective review of fistulizing Crohn's disease (CD) patient charts will capture data to measure health care resource utilization associated with the use of Infliximab for treatment of CD. Three health science centres/hospitals from Ontario are targeted to participate in the study, each site is expected to provide 30-40 patient charts with a target of 108 charts total.

Conditions

  • Crohn Disease

Interventions

BIOLOGICAL

Infliximab

None available in the protocol. This was a chart review study, therefore no Infliximab provided during the study.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2007-09-30
Completion
2007-09-30

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00705471 on ClinicalTrials.gov